Ozempic works with the bodys own ability to lower blood sugar and, as a result, can help lower a persons A1c
An important regulatory note: On December 22, 2025, the FDA approved Novo Nordisk's Wegovy tablet (oral semaglutide 25 mg) as the first oral GLP-1 receptor agonist for chronic weight management, with a national launch in January 2026
Ultimately, this means that Semaglutide reduces hunger, slows gastric emptying, and promotes a feeling of fullness making it a highly effective tool for weight loss, without feeling like youre depriving yourself of food
Semaglutide Dosage Calculator and Protocol Semaglutide has been FDA-approved for the treatment of both type 2 diabetes and chronic weight management, though each application requires a different dosing protocol
Gatorade Sports Science Institute